AI ScreeningAI ChatPricing
  1. JP-listed companies
  2. KYORIN Pharmaceutical Co., Ltd.
  3. Financials
  4. Revenue growth (%)

KYORIN Pharmaceutical Co., Ltd.【JP:4569】

Market cap
¥111.4B
P/E ratio
20.7x
SummaryFinancialsDividendsHistoryOwnershipWorkforce
Period EndRevenue growth (%) YoY (%)
Mar 31, 20258.8+59.67%
Mar 31, 20245.5-24.56%
Mar 31, 20237.3+186.33%
Mar 31, 20222.6-139.75%
Mar 31, 2021-6.4+101.25%
Mar 31, 2020-3.2-218.96%
Mar 31, 20192.7-165.61%
Mar 31, 2018-4.1+19.19%
Mar 31, 2017-3.4-161.21%
Mar 31, 20165.6+264.94%
Mar 31, 20151.5-62.25%
Mar 31, 20144.1+10.87%
Mar 31, 20133.7

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating expenses Operating income Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSAdjusted EPSDividend payout ratio (%)Dividend per shareEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)